Clarivate Plc is a British-American publicly traded analytics company (NYSE: CLVT) that provides transformative intelligence through enriched data, insights, analytics, workflow solutions, and expert services. Its operations focus on three main areas: academia and government, intellectual property, and life sciences and healthcare.
Headquartered in London, United Kingdom, with additional presence in Philadelphia, United States, the company employs over 12,000 people and serves more than 45,000 customers across 180 countries. Clarivate was established in its current form in 2016 after Onex Corporation and Baring Private Equity Asia acquired Thomson Reuters' Intellectual Property and Science business; it traces roots to earlier entities including the Institute for Scientific Information.
In February 2026, Clarivate announced it is pursuing the sale of its Life Sciences & Healthcare business unit.
Also known as Clarivate Analytics and Clarivate Analytics Plc.
Collaboration targets B‑cell malignancies, immunology and neurology with an oral, brain‑penetrant BTK degrader planned for Phase 3 in summer 2026.
